FindTrial
Sign In

Assessment of corneal aberrations before and after phototherapeutic keratectomy with corneal collagen cross linking in keratoconus patients

Aberration assessment in pre and post phototherapeutic keratectomy with corneal collagen cross linking in keratoconus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086890
Enrollment
40
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H186- Keratoconus

Interventions

Intervention1: Nil: Nil

Sponsors

Reshma C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with keratoconus who are undergoing phototherapeutic keratectomy with corneal collagen cross linking Thinnest pachymetry greater than 450 micrometers Age above 18 years

Exclusion criteria

Exclusion criteria: Contact lens wear within previous 3 weeks Pregnant women Corneal thickness at thinnest point less than 450 micrometers Post lasik ectasia

Design outcomes

Primary

MeasureTime frame
Phototherapeutic keratectomy combined with corneal collagen cross linking is effective in reducing high order aberrations especially coma in keratoconus patients It contributes to corneal surface regularization with a good safety profile over a 10 month follow upTimepoint: Phototherapeutic keratectomy combined with corneal collagen cross linking is effective in reducing high order aberrations especially coma in keratoconus patients It contributes to corneal surface regularization with a good safety profile over a 10 month follow up—

Secondary

MeasureTime frame
Change in visual acuityTimepoint: 1 month 4 months—

Countries

India

Contacts

Public ContactReshma C

Sankara eye hospital coimbatore

vijayaraghavan@sankaraeye.com9976488000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026